Last updated: February 20, 2026
What Is the Drug Identified by NDC 65162-0914?
NDC 65162-0914 corresponds to Albendazole tablets. Albendazole is an anthelmintic used to treat a variety of parasitic worm infections. It is manufactured by several pharmaceutical companies and is available as a generic medicine, with some branded formulations.
Market Size and Growth
Global Market
The global albendazole market was valued at approximately USD 300 million in 2020. It is projected to grow at a Compound Annual Growth Rate (CAGR) of 4-6% over the next five years, driven by increasing prevalence of parasitic infections in developing regions.
Regional Breakdown
| Region |
Market Size (2022, USD million) |
CAGR (2022-2027) |
Key Drivers |
| North America |
70 |
2-3% |
Rising awareness, higher detection rates |
| Europe |
40 |
2-4% |
Similar to North America, proactive health policies |
| Asia-Pacific |
130 |
6-8% |
High parasitic disease prevalence, improving healthcare infrastructure |
| Latin America |
30 |
3-5% |
Expanding healthcare, parasitic infections prevalence |
| Africa |
20 |
8-10% |
High disease burden, increasing healthcare access |
Key Market Drivers
- Rising prevalence of parasitic diseases (e.g., helminthiasis, filariasis)
- Increased healthcare initiatives and mass drug administration programs, especially in endemic regions
- Government and NGO-sponsored deworming campaigns
- Growing awareness of parasitic infections’ health impacts
Market Challenges
- Competition from generic manufacturers and biosimilars
- Pricing pressures in mature markets
- Regulatory hurdles for new formulations or delivery methods
Price Trends and Projections
Current Pricing
| Region |
Price per Tablet (USD) |
Supply Chain Notes |
| North America |
0.10 - 0.20 |
Mostly generic, low margins |
| Europe |
0.08 - 0.15 |
Availability of generics |
| Asia-Pacific |
0.03 - 0.06 |
Cost-sensitive markets |
| Africa |
0.02 - 0.05 |
High volume, low-cost sourcing |
Historical Price Trends
Between 2018 and 2022, prices have stabilized in mature markets due to increased generic competition. In contrast, prices in developing markets remain low but are expected to increase marginally over the next five years.
Future Price Projections (2023-2027)
- North America & Europe: Slight decrease in per-tablet price (~2-4%) owing to intensified generic competition.
- Asia-Pacific & Africa: Prices may increase modestly (~1-3%) owing to supply chain inflation and demand growth.
- Overall: The average global price per tablet is projected to remain within USD 0.02 - 0.20 range, with regional variations.
Key Factors Influencing Prices
- Generic competition saturation
- Manufacturing cost fluctuations (raw materials, labor)
- Regulatory approval processes
- Public health policies affecting supply and demand
Competitive Landscape
Major Players
- GlaxoSmithKline (GSK): Branded formulations, but limited due to patent expiry
- Apotex, Teva, Mylan, Sandoz: Significant generic manufacturers diffusing market prices
- Local producers in endemic regions
Market Entry Considerations
- Regulatory compliance with FDA, EMA, and other agencies
- Cost of manufacturing and scale
- Distribution network efficiency
Price Regulation and Patent Status
Albendazole’s patent expired globally between 2010 and 2012, resulting in widespread generic availability. Price regulation varies by region, with governments in many countries controlling or negotiating drug prices for public healthcare systems.
Summary
The albendazole market is mature with stable demand driven by public health initiatives. Price competition among generics keeps prices low in developed markets, while demand growth in endemic regions supports volume expansion. Price projections suggest stability in mature markets and marginal increases in developing regions over the next five years.
Key Takeaways
- The global albendazole market was valued at USD 300 million in 2020, growing at a CAGR of 4-6%.
- Prices per tablet typically range from USD 0.02 in low-income regions to USD 0.20 in high-income markets.
- Demand is driven by parasitic disease prevalence, public health campaigns, and healthcare infrastructure improvements.
- Market competition from numerous generic manufacturers constrains price increases.
- Regional disparities influence both market growth and pricing dynamics.
FAQs
1. What are the primary indications for albendazole?
It treats infections caused by worms such as roundworms, hookworms, whipworms, and tapeworms.
2. How does regional variation affect the price?
Prices are lower in developing regions due to high generic competition and higher in developed regions due to supply chain costs and regulatory premiums.
3. What are the key regulatory considerations?
Patent expiry has led to widespread generic competition; regulatory approval mainly involves demonstrating bioequivalence and ensuring manufacturing quality.
4. Are there any new formulations or delivery methods expected?
Current development focuses on improved formulations for pediatric administration and combination therapies; no major novel delivery methods are slated for near-term approval.
5. How will public health initiatives influence future demand?
Scaling up mass drug administration in endemic regions will sustain or increase demand, supporting market volume growth.
References
[1] Global Market Insights. (2022). Anthelmintic Drugs Market Size & Share.
[2] IQVIA. (2022). Global Sales Data, Anthelmintic Drugs.
[3] World Health Organization. (2021). Neglected Tropical Diseases: Soil-Transmitted Helminth Infections.
[4] Statista. (2023). Price trends for generic medicines in global markets.
[5] U.S. Food & Drug Administration. (2023). Drug Approvals and Regulations.
